Skip to main content
. 1999 May;10(5):1609–1619. doi: 10.1091/mbc.10.5.1609

Figure 11.

Figure 11

Schematic representation of DAG-activated, branched signaling pathways involving PKC and hmunc13. DAG levels are increased by such factors as hyperglycemia, phospholipase C (PLC) β/γ, and phospholipase D (PLD), resulting in activation of PKC and hmunc13 and leading to two separate signaling pathways, resulting in proliferation and differentiation or apoptosis.